The future of Ohio States MS/HSPA program

FacebookTwitterLinkedInInstagram

June 18, 2019

graduates of MSHSPA program standing with instructor
News Story Content

Tim Ulbrich, PharmD, RPh, was named the director of the Master of Science in Pharmaceutical Science – Health-System Pharmacy Administration (MS/HSPA) graduate program specialization in November 2018. His position is shared with The Ohio State University Wexner Medical Center and resulted from Jay Mirtallo’s retirement from the position on June 30, 2018.

As director of the MS/HSPA program, Ulbrich is responsible for the coordination and administration of the program with its residency partners, as well as student recruitment, teaching and advising student major projects, and serving as an advisor and advocate for medical center residents, assuring a tight integration between the graduate students’ residency training and classroom experiences. Ulbrich’s primary areas of expertise and research include personal finance for pharmacy professionals, residency training and education, teaching and learning curricula and evaluation of advanced patient care services in community pharmacy practice.

As the program nears its 60th anniversary, Ulbrich has big plans for the future. Keeping with Dr. Clifton Latiolais’ vision to “keep moving forward,” Ulbrich plans to offer two tracks of the program beginning in fall of 2020. One track will be a hybrid of in-person and online courses for those taking the program alongside residency training and the second track will be offered fully online, targeting working professionals that are emerging leaders within their organizations. These changes will allow the program to:

  • Be more accessible to those outside of Columbus, Ohio;
  • Bring in more diversity in practice sites into the curriculum;
  • Provide for more flexibility in the program schedule; and,
  • Leverage the expertise of the programs’ vast network of alumni.

Tim Ulbrich headshotFurthermore, this model will allow Ohio State to grow its’ national reputation as a leader in health-system pharmacy administration.

“The legacy of this program speaks for itself,” Ulbrich said. “What we are looking at now is how we maintain sustained excellence and growth.”